Stay updated on PF-06882961 Efficacy & Safety in Obesity Adults Clinical Trial
Sign up to get notified when there's something new on the PF-06882961 Efficacy & Safety in Obesity Adults Clinical Trial page.

Latest updates to the PF-06882961 Efficacy & Safety in Obesity Adults Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer now displays website revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check8 days agoChange DetectedThe 403 error view is replaced by the ClinicalTrials.gov record for Pfizer’s completed phase 2b obesity study, showing its design, eligibility criteria, locations, outcomes, and study documents.SummaryDifference91%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA sitewide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The clinical-trial record content is not available on the page.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the study page continues to show a 403 error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study details with an access-denied screen. This indicates restricted access to the study record on ClinicalTrials.gov, altering how users can interact with the page's primary content.SummaryDifference21%

Stay in the know with updates to PF-06882961 Efficacy & Safety in Obesity Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06882961 Efficacy & Safety in Obesity Adults Clinical Trial page.